Enhanced Applauds FDA Advisory Committee's Landmark Vote to Expand Legal Compounding Pathway for Peptides
Enhanced Group Inc. (NYSE: ENHA) the elite sports competition and personalized performance products company commended the United States Food & Drug Administrations (FDA) Pharmacy Compounding Advisory Committee (PCAC) for its vote last week recommending that BPC-157, KPV, TB-500, MOTS-c, Epitalon...